Victory Capital Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-80,149
Closed -$1.46M 2844
2021
Q4
$1.46M Sell
80,149
-5,577
-7% -$120K ﹤0.01% 1671
2021
Q3
$1.68M Buy
85,726
+18,252
+27% +$694K ﹤0.01% 1661
2021
Q2
$3.02M Sell
67,474
-3,290
-5% -$153K ﹤0.01% 1510
2021
Q1
$3.55M Sell
70,764
-230,268
-76% -$15.7M ﹤0.01% 1463
2020
Q4
$26.9M Buy
301,032
+266,882
+781% +$22.4M 0.03% 753
2020
Q3
$2.61M Buy
+34,150
New +$2.17M ﹤0.01% 1368

Other funds holding CELL

Victory Capital Management's CELL Position: Q1 2022 in Review

Victory Capital Management sold out of PhenomeX Inc. Common Stock (CELL) in Q1 2022, closing a stake of 80,149 shares — an estimated $1.46M sold.

Victory Capital Management first reported a position in CELL in Q3 2020 and held it in 6 quarters. The position peaked at $26.9M in Q4 2020. 130 funds tracked by Wall St. Rank hold CELL as of Q1 2022.

  • Victory Capital Management reported no remaining PhenomeX Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Victory Capital Management sold 80,149 PhenomeX Inc. Common Stock shares in Q1 2022, an estimated $1.46M.
  • Victory Capital Management first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 6 quarters.
  • Victory Capital Management's PhenomeX Inc. Common Stock position peaked at $26.9M in Q4 2020.
  • 130 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q1 2022.

Based on Victory Capital Management's 13F filing for Q1 2022, filed 4 May 2022.